Oral Drug Delivery Partner Delivers Patient-Optimised Products

Aptalis Pharmaceutical Technologies is known for overcoming even the most demanding oral drug delivery challenges. The company’s comprehensive portfolio of oral drug delivery technologies for bioavailability enhancement, custom release profiles and taste masking for orally disintegrating tablets (ODTs) and other dosage forms are employed in a customised approach to meet partners’ requirements.

As an experienced oral drug delivery partner to the global pharmaceutical industry, Aptalis is focused on delivering high-value products with robust, defensible proprietary positions for its partners that grow the commercial value of their portfolio. The company is committed to its partners’ success, providing flexible and tailored co-development and product out-licensing agreements for value-added Rx and OTC products across multiple therapeutic categories.

Aptalis provides integrated R&D and manufacturing facilities in the US and Europe, where its teams of experts apply a rich array of development, manufacturing and regulatory skills to successfully deliver patient-optimised medicines to its partners in various regions around the world.

CPhI Worldwide attendees are invited to meet with licensing representatives to learn how a partnership with Aptalis can advance their products towards commercial success.

Stand 31D62

Aptalis Pharmaceutical Technologies, www.aptalispharmatech.com.